Photo of Bahareh Bahadini, MD

Bahareh Bahadini, MD

1157 Swallow Lane
Simi Valley, CA 93065
1998.7 miles away
Speaks: Persian (Farsi) and English
map

City of Hope - Simi Valley

1157 Swallow Lane, Simi Valley, CA 93065

Are you covered?

Check to see if your insurance is covered by this provider.

About Bahareh Bahadini

Bahareh Bahadini, M.D., brought her expertise in hematology and oncology to City of Hope in 2014 after more than a decade at North Valley Hematology/Oncology Group in Mission Hills, California. Dr. Bahadini’s training includes a residency at St. Mary Medical Center and a fellowship in hematology and oncology at City of Hope, including a year of research investigating genetic factors involved in breast cancer. She received her doctorate from the USC School of Medicine and received Master of Science degrees in both pathology and applied physiology at the University of Health Sciences/Chicago Medical School.

Dr. Bahadini founded and has been actively involved in the Wellness Through Awareness integrative medicine program at Providence Holy Cross Medical Center since 2007.

Board Certifications
  • American Board of Internal Medicine, Medical Oncology
City of Hope - Simi Valley
1157 Swallow Lane
Simi Valley, CA 93065

City of Hope - Thousand Oaks
425 Haaland Drive, Suite 101
Thousand Oaks, CA 91361

Affiliated Locations
Providence Holy Cross Medical Center

Clinical Interests

  • Aids Related Malignancies
  • Anaplastic Meningioma
  • Atypical Meningioma
  • Bladder Cancer Genomics
  • Brain Cancer Genomics
  • Breast Cancer
  • Breast Cancer Chemotherapy
  • Breast Cancer Genomics
  • Cancer
  • Cancer Chemotherapy
  • Cancer During Pregnancy
  • Cancer Genomics
  • Cancer Pain
  • Cancer Rehabilitation
  • Cancer Related Anxiety Disorder
  • Cancer Related Bereavement Disorder
  • Cancer Related Depression
  • Cancer Related Fatigue
  • Cancer Related Psychiatric Disorder
  • Cancer Related Stress Disorder
  • Cancer Risk Assessment
  • Cancer Survivor
  • Carcinoma Of Unknown Primary
  • Cervical Cancer Genomics
  • Chemoradiation
  • Clear Cell Meningioma
  • Clinical Trials
  • Colon Cancer Genomics
  • Crizotinib
  • Egfr Mutation
  • Egfr Translocation
  • Endocrine Complications Of Cancer Therapy
  • Endometrial Cancer Genomics
  • Epithelioid Hemangioendothelioma
  • Epithelioid Malignant Peripheral Nerve Sheath Tumor
  • Erlotinib
  • Fibrous Meningioma
  • Gallbladder Cancer Genomics
  • Gastrointestinal (Gi) Cancer Genomics
  • Genitourinary Cancer Genomics
  • Germinoma
  • Giant Cell Tumor Of The Bone
  • Gynecologic Cancer Genomics
  • Head And Neck Cancer
  • Head And Neck Cancer Genomics
  • Histiocytic Sarcoma
  • Immature Teratoma
  • Leukemia Genomics
  • Liver Cancer Genomics
  • Lung Cancer Genomics
  • Lymphedema Therapy
  • Lymphoma Genomics
  • Melanoma Genomics
  • Melanoma Of The Rectum
  • Melanoma On Foot
  • Melanoma On Leg
  • Melanoma On Toe
  • Melanoma On Trunk
  • Melanoma Surgery
  • Melanotic Schwannoma
  • Meningeal Melanoma
  • Metastatic Liver Cancer
  • Mucosal Melanoma
  • Musculoskeletal Tumor
  • Myeloproliferative Diseases
  • Non Germinomatous Germ Cell Tumor
  • Non Hodgkin Lymphoma
  • Oral Complications Of Cancer
  • Oral Lesions
  • Pancreatic Cancer Genomics
  • Plasma Cell Dyscrasia
  • Prostate Cancer Genomics
  • Pulmonary Metastases
  • Rectal Cancer Genomics
  • Renal Cancer Genomics
  • Retroperitoneal Mass
  • Sarcoma Genomics
  • Side Effects Of Cancer Treatment
  • Skin Cancer Genomics
  • Squamous Cell Carcinoma Of The Head And Neck
  • Squamous Cell Carcinoma Of The Tongue
  • Stomach Cancer Genomics
  • Supratentorial Primitive Neuroectodermal Tumor
  • Targeted Molecular Therapy
  • Teratoma With Malignant Transformation
  • Thoracic Cancer
  • Thyroid Cancer Genomics
  • Tracheal Cancer
  • Unknown Primary Cancer
  • Vaginal Melanoma